MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN, is the Clinical Program Director for Oncology at the Johns Hopkins Hospital and the Johns Hopkins Health System. Dr Olsen works work closely with JH oncology nurse leaders, oncology physician leaders, and directly with clinical staff to ensure best practice and streamlined coordination of care throughout the Johns Hopkins Health System. She collaborates with oncology service line leadership to ensure that oncology core competencies and standards of care are consistent and harmonized throughout the Johns Hopkins Cancer service line.  

Dr Olsen serves as adjunct faculty for the Johns Hopkins School of Nursing and Faculty Associate at the University of Maryland School Of Nursing. She is Co-chair of the Johns Hopkins Health System Venous Access Device Committees and central line-associated bloodstream infection (CLABSI) reduction committee. She is currently the lead editor for the 2nd edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (2023) and the Safe Handling of Hazardous Drugs 4th ed (2024). Dr Olsen has published and extensively presented on the topic of safe handling of hazardous drugs and the adverse effects for health care workers who handle these drugs.  

As an instructor and consultant, Dr Olsen has traveled to countries including Singapore, UAE, China, Bulgaria, and Japan to improve nursing education related to cancer and cancer treatment and to increase awareness of HD exposure risks and safe handling.